Myrthe E. Reiche

554 total citations
17 papers, 302 citations indexed

About

Myrthe E. Reiche is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Myrthe E. Reiche has authored 17 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 5 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Myrthe E. Reiche's work include Atherosclerosis and Cardiovascular Diseases (8 papers), Immune Cell Function and Interaction (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Myrthe E. Reiche is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (8 papers), Immune Cell Function and Interaction (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Myrthe E. Reiche collaborates with scholars based in Netherlands, Germany and United States. Myrthe E. Reiche's co-authors include Esther Lutgens, Menno P.J. de Winther, Pascal Kusters, Kikkie Poels, Tom Seijkens, Mandy M. T. van Leent, Willem J. M. Mulder, Stephan Huveneers, Ulrike Lössner and Mathias Faßhauer and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Scientific Reports.

In The Last Decade

Myrthe E. Reiche

16 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Myrthe E. Reiche Netherlands 8 127 109 72 71 46 17 302
Hang Xie China 9 74 0.6× 55 0.5× 86 1.2× 80 1.1× 59 1.3× 30 287
Rekha Badiger United Kingdom 6 52 0.4× 93 0.9× 26 0.4× 89 1.3× 43 0.9× 9 308
Anni Innamaa United Kingdom 5 209 1.6× 41 0.4× 20 0.3× 89 1.3× 49 1.1× 13 343
Margarita Blanes Spain 7 70 0.6× 36 0.3× 100 1.4× 127 1.8× 29 0.6× 13 287
Julia Martínez-Sánchez Spain 9 31 0.2× 57 0.5× 23 0.3× 69 1.0× 19 0.4× 20 233
Fabio De Luca Italy 8 137 1.1× 53 0.5× 109 1.5× 34 0.5× 27 0.6× 12 307
Toshihiro Gi Japan 9 44 0.3× 20 0.2× 73 1.0× 39 0.5× 26 0.6× 31 224
Genki Usui Japan 9 80 0.6× 26 0.2× 29 0.4× 100 1.4× 42 0.9× 25 292
Su Jung Han South Korea 8 87 0.7× 69 0.6× 14 0.2× 102 1.4× 37 0.8× 17 360

Countries citing papers authored by Myrthe E. Reiche

Since Specialization
Citations

This map shows the geographic impact of Myrthe E. Reiche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myrthe E. Reiche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myrthe E. Reiche more than expected).

Fields of papers citing papers by Myrthe E. Reiche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myrthe E. Reiche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myrthe E. Reiche. The network helps show where Myrthe E. Reiche may publish in the future.

Co-authorship network of co-authors of Myrthe E. Reiche

This figure shows the co-authorship network connecting the top 25 collaborators of Myrthe E. Reiche. A scholar is included among the top collaborators of Myrthe E. Reiche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myrthe E. Reiche. Myrthe E. Reiche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Reiche, Myrthe E., et al.. (2025). A CASE OF DIFFUSE CORONARY ARTERY VASOSPASM AFTER CORONARY ARTERY BYPASS GRAFT SURGERY WITH POSSIBLE KOUNIS SYNDROME. Journal of the American College of Cardiology. 85(12). 3620–3620.
2.
Han, Yilin, et al.. (2024). Microgravity Effect on Pancreatic Islets. Cells. 13(18). 1588–1588. 1 indexed citations
3.
Kusters, Pascal, Myrthe den Toom, Linda Beckers, et al.. (2023). Deficiency of germinal center kinase TRAF2 and NCK-interacting kinase (TNIK) in B cells does not affect atherosclerosis. Frontiers in Cardiovascular Medicine. 10. 1171764–1171764. 1 indexed citations
4.
Reiche, Myrthe E., Kikkie Poels, Claudia M. van Tiel, et al.. (2022). Adipocytes control hematopoiesis and inflammation through CD40 signaling. Haematologica. 108(7). 1873–1885. 9 indexed citations
5.
Reiche, Myrthe E., et al.. (2021). Apolipoprotein A1 deficiency in mice primes bone marrow stem cells for T cell lymphopoiesis. Journal of Cell Science. 135(5). 7 indexed citations
6.
Reiche, Myrthe E., Kikkie Poels, Claudia M. van Tiel, et al.. (2021). Abstract 101: B1b Cell Homeostasis Is Maintained By Cd40 In Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 41(Suppl_1). 1 indexed citations
7.
Poels, Kikkie, Mandy M. T. van Leent, Myrthe E. Reiche, et al.. (2020). Antibody-Mediated Inhibition of CTLA4 Aggravates Atherosclerotic Plaque Inflammation and Progression in Hyperlipidemic Mice. Cells. 9(9). 1987–1987. 69 indexed citations
8.
Poels, Kikkie, Mandy M. T. van Leent, C. Boutros, et al.. (2020). Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis. JACC CardioOncology. 2(4). 599–610. 101 indexed citations
9.
Aarts, Suzanne A. B. M., Myrthe E. Reiche, Myrthe den Toom, et al.. (2019). Depletion of CD40 on CD11c+ cells worsens the metabolic syndrome and ameliorates hepatic inflammation during NASH. Scientific Reports. 9(1). 14702–14702. 16 indexed citations
10.
Reiche, Myrthe E., et al.. (2019). B-Cell Cd40 Protects Against Atherosclerosis In Hypercholesterolemic Mice. Atherosclerosis. 287. e25–e25. 1 indexed citations
11.
Reiche, Myrthe E., Myrthe den Toom, Lisa Willemsen, et al.. (2019). Deficiency of T cell CD40L has minor beneficial effects on obesity-induced metabolic dysfunction. BMJ Open Diabetes Research & Care. 7(1). e000829–e000829. 7 indexed citations
12.
Willemsen, Lisa, Annette E. Neele, Saskia van der Velden, et al.. (2019). Peritoneal macrophages have an impaired immune response in obesity which can be reversed by subsequent weight loss. BMJ Open Diabetes Research & Care. 7(1). e000751–e000751. 11 indexed citations
13.
Poels, Kikkie, Myrthe den Toom, Myrthe E. Reiche, et al.. (2019). Cardiovascular Oncology: Exploring The Effects Of Immune Checkpoint Inhibitors On Experimental Atherosclerosis. Atherosclerosis. 287. e99–e99. 1 indexed citations
14.
Aarts, Suzanne A. B. M., Myrthe E. Reiche, Myrthe den Toom, et al.. (2018). Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction. PLoS ONE. 13(8). e0202150–e0202150. 5 indexed citations
15.
Aarts, Suzanne A. B. M., Tom Seijkens, Pascal Kusters, et al.. (2018). Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis. The Journal of Pathology. 247(4). 471–480. 15 indexed citations
16.
Stepan, Holger, Myrthe E. Reiche, Susanne Schrey-Petersen, et al.. (2010). Serum levels of the adipokine lipocalin-2 are increased in preeclampsia. Journal of Endocrinological Investigation. 33(9). 629–632. 19 indexed citations
17.
Reiche, Myrthe E., Anette Bachmann, Ulrike Lössner, et al.. (2009). Fibroblast Growth Factor 19 Serum Levels: Relation to Renal Function and Metabolic Parameters. Hormone and Metabolic Research. 42(3). 178–181. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026